+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
GLP-1 Receptor Agonist Market Report 2025 - Product Thumbnail Image

GLP-1 Receptor Agonist Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Cell & Gene Therapy Market - Global Forecast 2025-2032 - Product Thumbnail Image

Cell & Gene Therapy Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 194 Pages
  • Global
From
Antisense & RNAi Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Antisense & RNAi Therapeutics Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 198 Pages
  • Global
From
From
From
From
From
Factor VIIa Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Factor VIIa Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator